MGTA NASDAQ
Magenta Therapeutics, Inc.
1W: -6.0%
1M: -10.9%
3M: -0.1%
1Y: -65.5%
3Y: -90.0%
5Y: -94.7%
$0.70
Last traded 2023-09-11 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$531M
+42.0% ▲
5Y CAGR: +26.9%
Total Liabilities
$38M
+74.3% ▲
5Y CAGR: +13.0%
Shareholders Equity
$493M
+40.0% ▲
5Y CAGR: +28.4%
Cash & Investments
$404M
+46.9% ▲
5Y CAGR: +22.6%
Total Debt
$1M
-7.0% ▼
Net Debt
-$50M
-133.3% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2020 | FY2021 | FY2022 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $58M | $132M | $58M | $23M | $51M |
| Short-Term Investments | $91M | $45M | $54M | $252M | $353M |
| Cash & ST Investments | $149M | $177M | $112M | $275M | $404M |
| Net Receivables | $0 | $0 | $0 | $0 | $52K |
| Inventory | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $3M | $4M | $4M | $6M | $5M |
| Total Current Assets | $152M | $177M | $116M | $281M | $409M |
| Property, Plant & Equip. | $8M | $7M | $29M | $2M | $2M |
| Goodwill & Intangibles | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $82M | $110M |
| Other Non-Current Assets | $2M | $6M | $2M | $10M | $10M |
| Total Non-Current Assets | $10M | $13M | $31M | $93M | $121M |
| Total Assets | $162M | $190M | $147M | $374M | $531M |
| — Liabilities — | |||||
| Accounts Payable | $4M | $3M | $2M | $5M | $10M |
| Short-Term Debt | $0 | $0 | $4M | $320K | $367K |
| Deferred Revenue | $0 | $0 | $0 | $479K | $1M |
| Other Current Liabilities | $8M | $8M | $8M | $13M | $29M |
| Total Current Liabilities | $11M | $11M | $15M | $18M | $31M |
| Long-Term Debt | $0 | $0 | $26M | $1M | $1M |
| Other Non-Current Liab. | $6M | $6M | $0 | $2M | $6M |
| Total Non-Current Liabilities | $6M | $6M | $26M | $3M | $7M |
| Total Liabilities | $18M | $17M | $41M | $22M | $38M |
| — Equity — | |||||
| Common Stock | $49K | $59K | $61K | $31K | $43K |
| Retained Earnings | -$254M | -$326M | -$402M | -$174M | -$337M |
| Accumulated OCI | -$23K | -$30K | -$181K | $106K | $489K |
| Total Stockholders Equity | $144M | $173M | $106M | $352M | $493M |
| Total Liabilities & Equity | $162M | $190M | $147M | $374M | $531M |
| — Key Metrics — | |||||
| Total Debt | $0 | $0 | $30M | $1M | $1M |
| Net Debt | -$58M | -$132M | -$28M | -$21M | -$50M |
| Total Investments | $91M | $45M | $54M | $334M | $463M |
Debt lines follow our data vendor. Long-term debt can include lease obligations in some periods, so it may read higher than a company or press figure.